LucyRx and Abarca Health Complete Strategic Combination
LucyRx and Abarca Health today announced the completion of their previously announced strategic combination.
LucyRx Expands Pharmacy Access with the Addition of Mark Cuban Cost Plus Drug Company
LucyRx is expanding pharmacy access through a collaboration with Mark Cuban Cost Plus Drug Company, giving members more affordable prescription options while helping employers manage pharmacy costs.
Forbes: Merger of Abarca And LucyRx May Spur More PBM Deals
Forbes highlights the planned LucyRx and Abarca Health combination as part of a broader PBM market shift toward greater scale, innovation and accountability.
News is my Business: Abarca, LucyRx combine to serve 9M prescription users
News is my Business highlights the planned combination of Abarca Health and LucyRx, focusing on expanded scale, nationwide reach and the ability to serve more than 9 million members across commercial and government markets.
Pulse 2.0: Abarca Health And LucyRx Announce Strategic Combination To Create Modern Independent PBM
Learn how LucyRx and Abarca Health are combining to create a modern independent PBM, delivering scalable pharmacy benefits, specialty care expertise, and advanced healthcare technology.
MedCity News: Abarca Health and LucyRx to Combine to Scale Independent PBM Model
MedCity News examines the planned combination of LucyRx and Abarca Health, highlighting how the two independent PBMs aim to expand scale, strengthen transparency, and serve commercial and government clients amid growing scrutiny of the pharmacy benefit management industry.
Managed Healthcare Executive: 4 things to know about the Abarca/LucyRx merger
Managed Healthcare Executive examines the LucyRx and Abarca Health combination and its focus on scale, technology, and innovation in the PBM market.
LucyRx Founder and CEO David Blair Named EY US Entrepreneur Of The Year® 2026 Mid-Atlantic Award Winner
David Blair, Founder and CEO of LucyRx, has been named an EY US Entrepreneur Of The Year® 2026 Mid-Atlantic Award winner, recognizing his leadership, innovation, and impact in transforming prescription care.
Managed Healthcare Executive Covers LucyRx and Abarca Health Strategic Combination
Managed Healthcare Executive reported on the strategic combination of LucyRx and Abarca Health, two independent PBMs joining forces to serve more than 9 million members across the United States.
Forbes Highlights LucyRx and Abarca Health Strategic Combination as an Alternative to the Big Three PBMs
Forbes Highlights LucyRx and Abarca Health Strategic Combination as an Alternative to the Big Three PBMs.